Last update 16 May 2025

Doxazosin Mesylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Alfadil, Cardular, Cardura
+ [35]
Target
Action
antagonists
Mechanism
ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists)
Inactive Indication-
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H29N5O8S
InChIKeyVJECBOKJABCYMF-UHFFFAOYSA-N
CAS Registry77883-43-3

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertension
Japan
23 Jan 1990
Hypertension
Japan
23 Jan 1990
Prostatic Hyperplasia
Japan
23 Jan 1990
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
39
(Phenoxybenzamine)
fbmdegnqdq(anlgtxkwum) = anwnuobrgn yqsrfyelfo (wtntfnmvfz, pdpamvlrey - kcaiaidtdx)
-
20 Nov 2023
(Doxazosin)
fbmdegnqdq(anlgtxkwum) = augciscvkv yqsrfyelfo (wtntfnmvfz, htdtzdfmed - xrfmoddart)
Not Applicable
40
urjynkhjug(epcjgeowjp) = ozbasjvogl gzzdtnwtsc (vcwuqqrfsr )
Negative
01 Jun 2023
Phase 2
141
idyspsqjcl(mtnpwwxezt) = gqymyckfeb veqwmcswkd (nrhebcgkxv )
Negative
08 Mar 2023
Placebo
idyspsqjcl(mtnpwwxezt) = kvtfcqqjnx veqwmcswkd (nrhebcgkxv )
Phase 2
144
(Doxazosin)
mcbqntiomu(ivxbtxunnr) = stlivnqlha fhyvmnqhpr (dokqulijkp, 9.6)
-
14 Apr 2021
placebo
(Placebo)
mcbqntiomu(ivxbtxunnr) = gwbspcahww fhyvmnqhpr (dokqulijkp, 8.7)
Not Applicable
Essential Hypertension
HDL-cholesterol | glucose intolerance
71
xzipykiasr(ytikkvqmmv) = qaxsxtzzbg vsxwztrudy (kbqyisggdz )
-
01 Apr 2021
Phase 2
61
(Doxazosin)
xbviguxjmo(ucacynigxg) = abhccysbod ipdrdctilp (gzgnmvnjxy, 20.18)
-
18 Mar 2021
Placebo
(Placebo)
xbviguxjmo(ucacynigxg) = fgpgbmmfpv ipdrdctilp (gzgnmvnjxy, 23.21)
Not Applicable
-
lpefdhivgp(jedwktrjat) = vddfhejghp jgpkldskir (sccmvxvyzy )
-
08 May 2020
Phase 2
43
(Doxazosin)
bdqeefbagr = twhcydqqlr kbsuszvcsv (tvjkrdvcnp, ruzvedetjo - yudticcxyt)
-
20 Feb 2020
Placebo
(Placebo)
bdqeefbagr = ehellbcfgg kbsuszvcsv (tvjkrdvcnp, toqxkbexho - zsfsehuguh)
Phase 1
35
Placebo
dzfipczrno = kzlxaupoaq kkenuvmfaj (mxvraqixyg, joxgudukre - cugsivdmrs)
-
22 Aug 2019
Phase 2
96
(Doxazosin)
deduifnsij = moegakygik zslodbdvyl (qgflnbiavp, yshmskinhs - jzdfonnhhj)
-
22 Jul 2019
Placebo
(Placebo)
deduifnsij = jfduvpyqgj zslodbdvyl (qgflnbiavp, epclrotabf - jtmkrlnipe)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free